Jay de Groot has over 25 years of experience representing public and private companies, venture capital funds, and underwriters in corporate and securities matters, including mergers and acquisitions, public offerings and capital market transactions, across an array of industries and technologies.
Mr. de Groot has consummated more than $7 billion of merger and acquisition transactions with transactional values ranging from $5 million to over $1 billion. His experience includes all forms of buy-side and sell-side transactions including carveouts and divestitures, acquisitions of divisions and business units, cross-border deals, and auction transactions. Mr. de Groot has also represented clients in numerous securities offerings. He has helped raise over $2 billion in initial public offerings for Digirad, Nuvasive, Santarus, and Volcano Therapeutics and capital markets transactions for ALARIS Medical Systems, Cadence Pharmaceuticals, Chiron, Ignyta, IVAC Medical Systems, Twinlab Consolidated, and other publicly traded issuers.
In addition, Mr. de Groot regularly advises public companies on mergers and acquisitions, SEC reporting and compliance, and corporate governance, including Deere, Halozyme Therapeutics, Kyocera, Nokia, and Orasure Technologies.
Mr. de Groot also counsels a number of venture-backed and private equity-backed companies, many in the life sciences and technology sectors, as well as the funds that finance them. In the last several years, he has closed more than 80 venture capital and private equity financings with over $2 billion of aggregate proceeds and has represented many venture-backed companies in merger and acquisition transactions.
Beyond his legal experience, Mr. de Groot has significant business experience, having served as senior vice president and general counsel of two publicly-traded medical device and software companies, ALARIS Medical Systems and IVAC Medical Systems, where he was responsible for the corporate development, strategic planning, and legal functions. ALARIS was a $600 million publicly-traded company formed by the merger of IVAC Medical Systems and IMED, with 2,500 employees doing business in 120 countries. Prior to law school, Mr. de Groot was a Certified Public Accountant with KPMG.
Mr. de Groot serves on the board of directors of the International Bipolar Foundation. Previously, Mr. de Groot served on the board of directors of the UCSD Moores Cancer Center, CONNECT and Cleantech San Diego. Mr. de Groot has also held several leadership positions within the firm including his prior service on the firm’s board of directors and as the co-chair of the firm’s Emerging Company and Venture Capital Practice and his current service as co-chair of the Firm’s Ag Tech + Food Industry Group.
At Notre Dame Law School, Mr. de Groot served as an Editor of the Journal of Legislation and was a member of the Jessup International Moot Court Team.
Jay de Groot is recommended as a leading corporate lawyer by Best Lawyers In America, Chambers USA, Legal 500 US, PLC Which lawyer? Global Counsel Handbook, San Diego Daily Transcript, and San Diego Magazine.
©1996-2018 Morrison & Foerster LLP. All rights reserved.